Microbe Drug Association Prediction with Bernoulli Random Forests.

Authors

Jia Qu, Qing-Nuo Li, Zi-Hao Song, Jin-Cheng Zhao, Qing-Gang Bu, Ze-Kang Bian, Wan-Ling Xie

Published in

Journal of computational biology : a journal of computational molecular cell biology. Sep 11, 2025. Epub Sep 11, 2025.

Abstract

Due to the widespread use of antibiotics, many microbes have become drug-resistant. It is urgent to develop new antibiotics that can effectively combat drug-resistant microbes. Exploiting microbe-drug associations can help researchers make progress in drug development. In this paper, we develop for the first time a computational model of Bernoulli random forest (BRF) for microbe-drug association (BRFMDA) prediction. First, we introduced integrated drug similarity and integrated microbe similarity to construct feature of each microbe-drug pair. Second, based on known microbe-drug association, we obtained the features of all positive sample. Then, the same number of negative samples as the number of positive samples were chosen from unknown microbe-drug pairs. Next, we used a filter-based approach to reduce the dimension of features of positive and negative samples. Lastly, BRF was used to train features of positive and negative samples to predict microbe-drug associations. For validating the performance of BRFMDA, we took leave-one-out cross-validation (LOOCV) and fivefold cross-validation, as well as two types of case studies, to validate the prediction performance of BRFMDA. The results of cross-validation and case studies suggested that BRFMDA is a dependable model for predicting potential microbe-drug associations. Specifically, on the Microbe-Drug Association Database (MDAD), BRFMDA obtained an area under the curve (AUC) of 0.9134 in global LOOCV, 0.8958 in local LOOCV, and 0.8657 ± 0.0112 in fivefold cross-validation. On the abiofilm dataset, BRFMDA achieved an AUC of 0.9130 in global LOOCV, 0.8927 in local LOOCV, and 0.8844 ± 0.0137 in fivefold cross-validation.

PMID:
40932485
Bibliographic data and abstract were imported from PubMed on 11 Sep 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.